Not Just Another ChatGPT: Why Life Sciences Needs Domain-Specific AI
This blog explains what GPTs are, why using ChatGPT for life sciences isn’t ideal, and…
Certara2025年10月24日
Mathematical Modeling and the Monkey King: Use of Modeling for More Efficient NHP Study Design
Background Monkeys and humans share a strong bond, reflected not only in a shared genetic…
Certara2024年10月30日
4 Ways That Mechanistic Modeling Accelerates Bispecific (and Multispecific) Antibody Drug Development
With nine FDA-approved drugs today, 100+ in clinical development and several hundred in the preclinical…
Certara2024年9月12日
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Quantitative Systems Pharmacology (QSP) Modeling for Immunotherapy-induced Cytokine Release Syndrome
Cytokine Release Syndrome Cytokine release syndrome (CRS) is an inflammatory immune reaction that clinically manifests…
Certara2024年8月20日
Drug Discovery Platform Unlocks Scientific Data Access
The D360 desktop application supports drug discovery workflows, data access, and early development research data…
Certara2024年7月12日
How Drug Discovery Tools Aid Pharma Decision-Making
Learn how drug discovery tools can help pharmaceutical industry professionals make more informed decisions based…
Certara2024年3月22日
Understanding the Role of Your Discovery Asset’s Target Product Profile
If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly…
Certara2024年1月19日
Leveraging AI to Accelerate Drug Discovery: Vyasa Joins Certara
Applying Vyasa’s deep learning expertise to Certara products will enable our clients to expand how…
Certara2023年3月10日
